Please login to the form below

Not currently logged in
Email:
Password:

Global standard for medical writing outlined

International writers' associations aim to strengthen and share best practice
AMWA EMWA ISMPP

Three international medical writing associations have created a new global standard as part of a best practice drive.

It was published by the American Medical Writers Association (AMWA), European Medical Writers Association (EMWA), and the International Society for Medical Publication Professionals (ISMPP).

In a joint statement, they outlined the role of medical writing for scientific journals and presentations and presented a series of guidelines they hope will serve as a “valuable reference for ethical publication practices, worldwide”.

The unified position aims to highlight the value professional medical writing brings to evidence-based medicine in facilitating ethical, accurate and timely disclosure of research results.

EMWA member Dr Chris Winchester said: “By emphasising that professional medical writers are appropriately qualified and follow rigorous guidelines, the joint position statement seeks to strengthen the standing of the profession among journal editors, peer reviewers and readers.”

The statement builds on recommendations from the International Committee of Medical Journal Editors and Good Publication Practice guidelines, describing best practice and providing a template for disclosing medical writing support - particularly with regards to authorship of clinical trial reports.

Between them the AMWA, EMWA and ISMPP have over 6,500 members worldwide, and the joint statement is set to take precedence over each associations' previous positions and guidelines.

Article by
Rebecca Clifford

13th February 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Dimitri Azzopardi
Case-study for thalassaemia: Dimitri Azzopardi
An in-depth look at beta thalassaemia for Rare Disease Day...
Delivering change through better rare disease communications
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes....
Interim analysis clinical trials
Assessing the value of interim analyses in clinical trials
Why its important and when its needed...

Infographics